XENE
Xenon Pharmaceuticals Inc.
+0.49 (+0.86%)57.25USD413K成交股數5.5B市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-11-02下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 3 · 1.1M · 2 |
| 其中 10b5-1 計畫賣出 | 2 筆 |
| 近 180 天 買進 · 賣出金額 | 0.00 · 1.2M |
| 近 180 天 淨額 | −1.2M |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-01 | 09-03 | Svoronos Dawn | Director | M 選擇權執行 | 5.1K | 8.15 | 42K | 31.4K | SEC |
| 2026-08-28 | 08-31 | KENNEY CHRISTOPHER JOHN | Chief Medical Officer | S 公開市場賣出(10b5-1) | 700 | 60.98 | 43K | 2 | SEC |
| 2026-08-28 | 08-31 | KENNEY CHRISTOPHER JOHN | Chief Medical Officer | S 公開市場賣出(10b5-1) | 6.4K | 60.17 | 383K | 702 | SEC |
| 2026-08-11 | 08-13 | GANNON STEVEN | Director | S 公開市場賣出 | 10.0K | 64.06 | 641K | 1.9K | SEC |
| 2026-06-05 | 06-08 | PATOU GARY | Director | S 公開市場賣出(10b5-1) | 1.3K | 53.14 | 70K | 24.9K | SEC |
| 2026-06-05 | 06-08 | Cannon Gillian | Director | S 公開市場賣出(10b5-1) | 1.2K | 53.14 | 63K | 1.5K | SEC |
| 2026-06-01 | 06-03 | PATOU GARY | Director | M 選擇權執行 | 2.6K | – | – | 26.2K | SEC |
| 2026-06-01 | 06-03 | Gover Justin D. | Director | M 選擇權執行 | 2.6K | – | – | 2.6K | SEC |
| 2026-06-01 | 06-03 | Cannon Gillian | Director | M 選擇權執行 | 2.6K | – | – | 2.6K | SEC |
| 2026-06-01 | 06-03 | Svoronos Dawn | Director | M 選擇權執行 | 2.6K | – | – | 27.6K | SEC |
| 2026-06-01 | 06-03 | GAROFALO ELIZABETH A. | Director | M 選擇權執行 | 2.6K | – | – | 2.6K | SEC |
| 2026-06-01 | 06-03 | GANNON STEVEN | Director | M 選擇權執行 | 2.6K | – | – | 13.3K | SEC |
| 2026-06-01 | 06-03 | Svoronos Dawn | Director | F 繳稅扣股 | 1.4K | 53.41 | 76K | 26.2K | SEC |
| 2026-06-01 | 06-03 | Machado Patrick | Director | M 選擇權執行 | 2.6K | – | – | 2.6K | SEC |
| 2026-06-01 | 06-03 | GANNON STEVEN | Director | F 繳稅扣股 | 1.4K | 53.41 | 76K | 11.9K | SEC |
| 2026-05-12 | 05-13 | GANNON STEVEN | Director | M 選擇權執行 | 3.5K | 7.38 | 26K | 10.6K | SEC |
| 2026-03-13 | 03-13 | KENNEY CHRISTOPHER JOHN | Chief Medical Officer | S 公開市場賣出(10b5-1) | 1.4K | 55.23 | 78K | 7.1K | SEC |
| 2026-03-13 | 03-13 | DiFabio Andrea | Chief Legal Officer | S 公開市場賣出(10b5-1) | 1.3K | 55.23 | 74K | 7.3K | SEC |
| 2026-03-13 | 03-13 | MORTIMER IAN | PRESIDENT & CEO | S 公開市場賣出(10b5-1) | 7.3K | 55.23 | 404K | 19.9K | SEC |
| 2026-03-12 | 03-13 | KENNEY CHRISTOPHER JOHN | Chief Medical Officer | M 選擇權執行 | 3.8K | – | – | 8.5K | SEC |
| 2026-03-12 | 03-13 | DiFabio Andrea | Chief Legal Officer | M 選擇權執行 | 3.8K | – | – | 8.6K | SEC |
| 2026-03-12 | 03-13 | MORTIMER IAN | PRESIDENT & CEO | M 選擇權執行 | 12.5K | – | – | 27.2K | SEC |
| 2026-03-10 | 03-11 | KENNEY CHRISTOPHER JOHN | Chief Medical Officer | S 公開市場賣出(10b5-1) | 2.8K | 60.11 | 167K | 4.7K | SEC |
| 2026-03-10 | 03-11 | DiFabio Andrea | Chief Legal Officer | S 公開市場賣出(10b5-1) | 2.6K | 60.11 | 157K | 4.9K | SEC |
| 2026-03-10 | 03-11 | MORTIMER IAN | PRESIDENT & CEO | S 公開市場賣出(10b5-1) | 11.3K | 60.11 | 677K | 14.7K | SEC |
| 2026-03-09 | 03-11 | MORTIMER IAN | PRESIDENT & CEO | S 公開市場賣出(10b5-1) | 2.4K | 61.26 | 150K | 6.0K | SEC |
| 2026-03-09 | 03-11 | MORTIMER IAN | PRESIDENT & CEO | S 公開市場賣出(10b5-1) | 12.5K | 59.50 | 743K | 18.5K | SEC |
| 2026-03-09 | 03-11 | MORTIMER IAN | PRESIDENT & CEO | S 公開市場賣出(10b5-1) | 10.1K | 60.47 | 609K | 8.4K | SEC |
| 2026-03-09 | 03-11 | MORTIMER IAN | PRESIDENT & CEO | S 公開市場賣出(10b5-1) | 21.5K | 60.49 | 1.3M | 6.0K | SEC |
| 2026-03-09 | 03-11 | MORTIMER IAN | PRESIDENT & CEO | M 選擇權執行 | 105K | 4.75 | 499K | 111K | SEC |
| 2026-03-09 | 03-11 | MORTIMER IAN | PRESIDENT & CEO | M 選擇權執行 | 25.0K | 3.10 | 78K | 31.0K | SEC |
| 2026-03-09 | 03-11 | MORTIMER IAN | PRESIDENT & CEO | S 公開市場賣出(10b5-1) | 21.8K | 58.81 | 1.3M | 59.2K | SEC |
| 2026-03-09 | 03-11 | MORTIMER IAN | PRESIDENT & CEO | S 公開市場賣出(10b5-1) | 31.7K | 59.88 | 1.9M | 27.5K | SEC |
| 2026-03-09 | 03-11 | MORTIMER IAN | PRESIDENT & CEO | M 選擇權執行 | 75.0K | 8.40 | 630K | 81.0K | SEC |
| 2026-03-09 | 03-11 | KENNEY CHRISTOPHER JOHN | Chief Medical Officer | M 選擇權執行 | 7.5K | – | – | 7.5K | SEC |
| 2026-03-09 | 03-11 | MORTIMER IAN | PRESIDENT & CEO | S 公開市場賣出(10b5-1) | 43.3K | 59.26 | 2.6M | 72.7K | SEC |
| 2026-03-09 | 03-11 | DiFabio Andrea | Chief Legal Officer | M 選擇權執行 | 7.5K | – | – | 7.5K | SEC |
| 2026-03-09 | 03-11 | MORTIMER IAN | PRESIDENT & CEO | M 選擇權執行 | 20.0K | – | – | 26.0K | SEC |
| 2026-03-09 | 03-11 | MORTIMER IAN | PRESIDENT & CEO | S 公開市場賣出(10b5-1) | 65.0K | 62.06 | 4.0M | 6.0K | SEC |
| 2026-03-09 | 03-11 | MORTIMER IAN | PRESIDENT & CEO | S 公開市場賣出(10b5-1) | 61.7K | 60.08 | 3.7M | 6.0K | SEC |
| 2026-03-09 | 03-11 | MORTIMER IAN | PRESIDENT & CEO | M 選擇權執行 | 65.0K | 9.44 | 614K | 71.0K | SEC |
| 2026-01-02 | 01-02 | MORTIMER IAN | PRESIDENT & CEO | S 公開市場賣出(10b5-1) | 37.9K | 44.40 | 1.7M | 8.1K | SEC |
| 2026-01-02 | 01-02 | MORTIMER IAN | PRESIDENT & CEO | M 選擇權執行 | 40.0K | 7.49 | 300K | 46.0K | SEC |
| 2026-01-02 | 01-02 | MORTIMER IAN | PRESIDENT & CEO | S 公開市場賣出(10b5-1) | 2.1K | 44.93 | 93K | 6.0K | SEC |
| 2025-12-08 | 12-09 | MORTIMER IAN | PRESIDENT & CEO | S 公開市場賣出(10b5-1) | 2.0K | 46.32 | 93K | 6.0K | SEC |
| 2025-12-08 | 12-09 | MORTIMER IAN | PRESIDENT & CEO | S 公開市場賣出(10b5-1) | 8.8K | 45.59 | 402K | 8.0K | SEC |
| 2025-12-05 | 12-09 | MORTIMER IAN | PRESIDENT & CEO | S 公開市場賣出(10b5-1) | 14.4K | 45.03 | 647K | 16.8K | SEC |
| 2025-11-28 | 12-03 | MORTIMER IAN | PRESIDENT & CEO | S 公開市場賣出(10b5-1) | 97 | 45.01 | 4K | 31.2K | SEC |
| 2025-10-01 | 10-01 | MORTIMER IAN | PRESIDENT, CEO & INTERIM CFO | M 選擇權執行 | 25.0K | 7.69 | 192K | 56.3K | SEC |
| 2025-10-01 | 10-01 | MORTIMER IAN | PRESIDENT, CEO & INTERIM CFO | S 公開市場賣出(10b5-1) | 25.0K | 40.16 | 1.0M | 31.3K | SEC |
| 2025-06-05 | 06-06 | GANNON STEVEN | Director | S 公開市場賣出 | 3 | 30.48 | 91.44 | 7.1K | SEC |
| 2025-05-14 | 05-16 | GANNON STEVEN | Director | M 選擇權執行 | 5.1K | 12.57 | 65K | 7.1K | SEC |
| 2025-01-27 | 01-27 | MORTIMER IAN | PRESIDENT & CEO | S 公開市場賣出(10b5-1) | 1.1K | 41.07 | 47K | 31.3K | SEC |
| 2025-01-27 | 01-27 | MORTIMER IAN | PRESIDENT & CEO | S 公開市場賣出(10b5-1) | 15.2K | 40.46 | 614K | 31.3K | SEC |
| 2025-01-27 | 01-27 | MORTIMER IAN | PRESIDENT & CEO | M 選擇權執行 | 15.2K | 17.76 | 269K | 46.5K | SEC |
| 2025-01-27 | 01-27 | MORTIMER IAN | PRESIDENT & CEO | M 選擇權執行 | 1.1K | 17.76 | 20K | 32.5K | SEC |
| 2025-01-24 | 01-27 | MORTIMER IAN | PRESIDENT & CEO | S 公開市場賣出(10b5-1) | 22.5K | 40.20 | 903K | 31.3K | SEC |
| 2025-01-24 | 01-27 | MORTIMER IAN | PRESIDENT & CEO | M 選擇權執行 | 22.5K | 17.76 | 399K | 53.8K | SEC |
| 2025-01-23 | 01-27 | MORTIMER IAN | PRESIDENT & CEO | S 公開市場賣出(10b5-1) | 16.2K | 40.08 | 650K | 31.3K | SEC |
| 2025-01-23 | 01-27 | MORTIMER IAN | PRESIDENT & CEO | M 選擇權執行 | 16.2K | 17.76 | 288K | 47.5K | SEC |
| 2024-12-18 | 12-19 | AULIN SHERRY | Chief Financial Officer | S 公開市場賣出 | 7.2K | 41.23 | 297K | 0 | SEC |
| 2024-12-18 | 12-19 | AULIN SHERRY | Chief Financial Officer | F 繳稅扣股 | 2.1K | 41.28 | 88K | 7.2K | SEC |
| 2024-12-18 | 12-19 | AULIN SHERRY | Chief Financial Officer | M 選擇權執行 | 16.0K | 11.58 | 185K | 16.0K | SEC |
| 2024-12-18 | 12-19 | AULIN SHERRY | Chief Financial Officer | M 選擇權執行 | 9.3K | 9.44 | 88K | 9.3K | SEC |
| 2024-12-18 | 12-19 | AULIN SHERRY | Chief Financial Officer | F 繳稅扣股 | 4.5K | 41.28 | 185K | 11.5K | SEC |
| 2024-12-18 | 12-19 | AULIN SHERRY | Chief Financial Officer | S 公開市場賣出 | 11.5K | 41.19 | 474K | 0 | SEC |
| 2024-11-22 | 11-22 | PATOU GARY | Director | M 選擇權執行 | 3.5K | 7.38 | 26K | 27.1K | SEC |
| 2024-11-22 | 11-22 | PATOU GARY | Director | S 公開市場賣出 | 2.0K | 41.05 | 84K | 23.6K | SEC |
| 2024-11-22 | 11-22 | PATOU GARY | Director | S 公開市場賣出 | 2.9K | 41.11 | 117K | 23.6K | SEC |
| 2024-11-22 | 11-22 | PATOU GARY | Director | F 繳稅扣股 | 649 | 39.80 | 26K | 26.4K | SEC |
| 2024-11-22 | 11-22 | PATOU GARY | Director | F 繳稅扣股 | 1.0K | 39.80 | 42K | 25.6K | SEC |
| 2024-11-22 | 11-22 | PATOU GARY | Director | M 選擇權執行 | 3.1K | 13.48 | 42K | 26.7K | SEC |
| 2024-03-08 | 03-11 | GAROFALO ELIZABETH A. | Director | S 公開市場賣出 | 2.1K | 45.69 | 96K | 0 | SEC |
| 2024-03-08 | 03-11 | GAROFALO ELIZABETH A. | Director | F 繳稅扣股 | 1.4K | 46.16 | 65K | 2.1K | SEC |
| 2024-03-08 | 03-11 | GAROFALO ELIZABETH A. | Director | M 選擇權執行 | 3.5K | 18.56 | 65K | 3.5K | SEC |
| 2024-03-07 | 03-08 | ROBIN SHERRINGTON | EVP, Strategy & Innovation | M 選擇權執行 | 1.2K | 9.85 | 12K | 9.6K | SEC |
| 2024-03-07 | 03-08 | GANNON STEVEN | Director | S 公開市場賣出 | 2.0K | 46.20 | 92K | 2.0K | SEC |
| 2024-03-07 | 03-08 | GANNON STEVEN | Director | S 公開市場賣出 | 5.0K | 46.30 | 232K | 4.0K | SEC |
| 2024-03-07 | 03-08 | GANNON STEVEN | Director | S 公開市場賣出 | 5.0K | 46.25 | 231K | 9.0K | SEC |
| 2024-03-07 | 03-08 | GANNON STEVEN | Director | S 公開市場賣出 | 1.0K | 46.45 | 46K | 14.0K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| FMR LLC | 9.6M | 582M | 新進 | 新進 |
| BlackRock, Inc. | 7.5M | 454M | 新進 | 新進 |
| Avoro Capital Advisors LLC | 5.8M | 349M | 新進 | 新進 |
| Polar Capital Holdings Plc | 4.6M | 276M | 新進 | 新進 |
| Driehaus Capital Management LLC | 4.4M | 267M | 新進 | 新進 |
| Jupiter Topco LLC | 4.2M | 253M | 新進 | 新進 |
| JPMORGAN CHASE & CO | 2.6M | 157M | 新進 | 新進 |
| Capital International Investors | 2.4M | 143M | 新進 | 新進 |
| STATE STREET CORP | 2.0M | 119M | 新進 | 新進 |
| Two Sigma TWO SIGMA INVESTMENTS, LP | 1.6M | 99.2M | 新進 | 新進 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 1.6M | 97.5M | 新進 | 新進 |
| Affinity Asset Advisors, LLC | 1.6M | 96.3M | 新進 | 新進 |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 1.5M | 91.0M | 新進 | 新進 |
| ALLIANCEBERNSTEIN L.P. | 1.6M | 90.8M | 新進 | 新進 |
| FRANKLIN RESOURCES INC | 1.4M | 86.8M | 新進 | 新進 |
| WELLINGTON MANAGEMENT GROUP LLP | 1.4M | 86.0M | 新進 | 新進 |
| 城堡 CITADEL ADVISORS LLC | 1.4M | 84.6M | 新進 | 新進 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.4M | 82.7M | 新進 | 新進 |
| Siren, L.L.C. | 1.3M | 79.6M | 新進 | 新進 |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 1.3M | 77.9M | 新進 | 新進 |
| Pictet Asset Management Holding SA | 1.2M | 71.6M | 新進 | 新進 |
| BRAIDWELL LP | 1.1M | 68.3M | 新進 | 新進 |
| Nuveen, LLC | 993K | 59.9M | 新進 | 新進 |
| Invesco Ltd. | 903K | 54.5M | 新進 | 新進 |
| ORBIMED ADVISORS LLC | 892K | 53.9M | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 316 +25 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 316 / 0 / 0 / 0 |
| 機構合計持股 · 佔流通股 | 101M · 100.0% |
| 合計季末市值 | 5.7B |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 6.3M |
|---|---|
| 與上期比 | +11.9% |
| 佔流通股數 | 6.55% |
| 日均成交量 | 698K |
| 回補天數 | 9.1 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 6.3M | +11.9% | 6.55% | 698K | 9.1 |
| 2026-08-14 | 5.7M | +5.3% | 5.85% | 619K | 9.2 |
| 2026-07-31 | 5.4M | -15.0% | 5.56% | 735K | 7.3 |
| 2026-07-15 | 6.3M | +1.3% | 6.54% | 1.8M | 3.6 |
| 2026-06-30 | 6.3M | +42.0% | 6.46% | 2.1M | 3.0 |
| 2026-06-15 | 4.4M | +9.0% | 4.55% | 1.4M | 3.2 |
| 2026-05-29 | 4.0M | +5.5% | 4.18% | 1.4M | 2.9 |
| 2026-05-15 | 3.8M | -7.6% | 3.96% | 948K | 4.0 |
| 2026-04-30 | 4.1M | -14.5% | 4.28% | 899K | 4.6 |
| 2026-04-15 | 4.9M | +0.1% | 5.01% | 902K | 5.4 |
| 2026-03-31 | 4.9M | -11.0% | 5.01% | 1.4M | 3.5 |
| 2026-03-13 | 5.5M | -1.5% | 5.63% | 3.2M | 1.7 |
| 2026-02-27 | 5.5M | +2.9% | 5.71% | 817K | 6.8 |
| 2026-02-13 | 5.4M | -2.9% | 5.56% | 729K | 7.4 |
| 2026-01-30 | 5.5M | +3.2% | 5.72% | 844K | 6.6 |
| 2026-01-15 | 5.4M | -9.4% | 5.55% | 1.2M | 4.4 |
| 2025-12-31 | 5.9M | +3.6% | 6.12% | 720K | 8.2 |
| 2025-12-15 | 5.7M | -2.9% | 5.91% | 803K | 7.1 |
| 2025-11-28 | 5.9M | -2.5% | 6.08% | 800K | 7.4 |
| 2025-11-14 | 6.0M | +4.5% | 6.24% | 820K | 7.4 |
| 2025-10-31 | 5.8M | -5.9% | 5.97% | 792K | 7.3 |
| 2025-10-15 | 6.1M | -20.2% | 6.35% | 760K | 8.1 |
| 2025-09-30 | 7.7M | +9.4% | 7.96% | 800K | 9.6 |
| 2025-09-15 | 7.0M | +1.9% | 7.27% | 630K | 11.2 |
| 2025-08-29 | 6.9M | +0.2% | 7.13% | 676K | 10.2 |
| 2025-08-15 | 6.9M | -1.2% | 7.12% | 1.2M | 5.7 |